MCAP$2.36T-5.44%
BTC$69,320-4.23%ETH$1,966-2.07%SOL$81.32+0.23%XRP$1.03+0.31%
GOLD$3,891+0.13%
OIL$96.73+0.95%
STOCKTSLA$397.45+1.70%STOCKNVDA$166.19-4.34%STOCKAAPL$354.88-0.14%STOCKCOIN$130.67-4.11%STOCKMSTR$114.41-6.49%
BTC DOM59.0%
FEAR & GREED20Extreme Fear
Updated
Breaking crypto news, seconds after it happens

Whale alerts, listings and market-moving headlines on Telegram.

Join Telegram
Price Analysis

Injective and Lighter Lead Top 200 Crypto Gainers

Injective and Lighter paced the top 200 cryptocurrencies by market capitalization over a 24-hour period, both posting gains of 9.6%.

Injective and Lighter Lead Top 200 Crypto Gainers
Image: BullishMarketCap

Injective and Lighter led the top 200 digital assets by market capitalization over the past 24 hours, each recording a 9.6% price increase amid varying market catalysts.

The list

Get whale alerts first

Instant Telegram notifications for large on-chain moves.

Join Telegram
  • Injective, $INJ, +9.6%, $8.18
  • Lighter, $LIT, +9.6%, $3.36
  • NVIDIA (bStocks Tokenized Stock), $NVDAB, +8.8%, $169.54
  • Sonic, $S, +8.6%, $0.0381
  • LayerZero, $ZRO, +6.0%, $1.62

What moved them

  • Injective ($INJ): Moved as the network opened a governance vote on the Veyra upgrade for cross-chain trading, ahead of a scheduled November 24 launch.
  • Lighter ($LIT): Posted a 9.6% gain with no clear news catalyst in our coverage.
  • NVIDIA (bStocks Tokenized Stock) ($NVDAB): Gained 8.8% with $273.4M in 24-hour volume, though no clear news catalyst was found in our coverage.
  • Sonic ($S): Advanced 8.6% with 24-hour volume at $33.1M and no clear news catalyst in our coverage.
  • LayerZero ($ZRO): Rose 6.0% with $73.2M in 24-hour volume, and no clear news catalyst in our coverage.

This list reflects market data only and is not investment advice.

#Crypto#Altcoins#MarketUpdate

Source: coingecko.com

This article is for information only and is not investment advice. BullishMarketCap news is produced with AI assistance from public sources and reviewed by our editors; see our editorial policy. Spotted an error? Tell us.

More Price Analysis

View all →